SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 228 filers reported holding SAGE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $145 | -99.8% | 7 | -99.6% | 0.00% | -100.0% |
| Q2 2023 | $81,721 | +12.1% | 1,738 | 0.0% | 0.06% | +6.8% |
| Q1 2023 | $72,927 | +10.0% | 1,738 | 0.0% | 0.06% | +3.5% |
| Q4 2022 | $66,287 | -2.5% | 1,738 | 0.0% | 0.06% | +3.6% |
| Q3 2022 | $68,000 | +21.4% | 1,738 | 0.0% | 0.06% | +34.1% |
| Q2 2022 | $56,000 | -6.7% | 1,738 | -3.9% | 0.04% | +2.5% |
| Q1 2022 | $60,000 | -24.1% | 1,809 | -2.2% | 0.04% | -21.6% |
| Q4 2021 | $79,000 | -9.2% | 1,849 | -6.0% | 0.05% | -16.4% |
| Q3 2021 | $87,000 | -22.3% | 1,966 | 0.0% | 0.06% | -23.8% |
| Q2 2021 | $112,000 | -23.8% | 1,966 | 0.0% | 0.08% | -30.4% |
| Q1 2021 | $147,000 | -12.0% | 1,966 | +1.9% | 0.12% | -18.4% |
| Q4 2020 | $167,000 | – | 1,930 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |